UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000049258
Receipt No. R000056101
Scientific Title Alleviation degree of motion sickness symptoms by chewing peppermint gum -confirming the effectivity in bus-
Date of disclosure of the study information 2022/10/19
Last modified on 2022/10/19 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Alleviation degree of motion sickness symptoms by chewing peppermint gum
Acronym Alleviation degree of motion sickness symptoms by chewing peppermint gum
Scientific Title Alleviation degree of motion sickness symptoms by chewing peppermint gum -confirming the effectivity in bus-
Scientific Title:Acronym Alleviation degree of motion sickness symptoms by chewing peppermint gum
Region
Japan

Condition
Condition motion sickness
Classification by specialty
Oto-rhino-laryngology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Aim of this study is to confirm the alleviation degree of chewing peppermint scented gum for motion sickness symptoms that occur when using a smartphone in bus.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Numerical subjective evaluation value of discomfort
Key secondary outcomes Results of questioner about motion sickness symptoms

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Chewing peppermint gum (two pieces)
Interventions/Control_2 No treatment
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >=
Gender Male and Female
Key inclusion criteria A healthy adult
He/she has experience that occur motion sickness
Consent to participate this experiment in writing
Key exclusion criteria Pregnant and breast-feeder
Who has food allergies for peppermint gum
Too sensitive to motion sickness
Do not feel any discomfort from motion sickness symptoms
Who hates mint scented foods
Target sample size 50

Research contact person
Name of lead principal investigator
1st name Masaki
Middle name
Last name OGAWA
Organization Mie University
Division name Faculty of engineering
Zip code 5148507
Address 1577 Kurimamachiya-cho Tsu city, Mie
TEL +81592319459
Email ogawa@ai.info.mie-u.ac.jp

Public contact
Name of contact person
1st name Masaki
Middle name
Last name OGAWA
Organization Mie University
Division name Faculty of engineering
Zip code 5148507
Address 1577 Kurimamachiya-cho Tsu city, Mie
TEL +81592319459
Homepage URL
Email ogawa@ai.info.mie-u.ac.jp

Sponsor
Institute Mie University
Institute
Department

Funding Source
Organization LOTTE CO., LTD.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Faculty of engineering, Mie University
Address 1577 Kurimamachiya-cho Tsu city, Mie
Tel 0592319466
Email eng-somu@eng.mie-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 10 Month 19 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 44
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2022 Year 03 Month 01 Day
Date of IRB
2022 Year 05 Month 11 Day
Anticipated trial start date
2022 Year 06 Month 01 Day
Last follow-up date
2022 Year 07 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 10 Month 19 Day
Last modified on
2022 Year 10 Month 19 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056101